Bridging the gap between emerging market potential & developed market demand.
Anahit is a Toronto-based company in the international cannabis industry committed to bridging the gap between the emerging market potential and the developed market demand, following a global seed to retail sale model. This includes cultivation in emerging, regulated jurisdictions where the best natural climates can be utilized for low-cost, high-quality outdoor cannabis production. In addition to this, use of the state-of-the-art extraction systems produces extracts for local and export markets.
The international operations are supported by Canadian technical experts, that introduce Health Canada approved methodology to Anahit-owned (or leased) farms and operations, which include growing techniques, extraction, storage, and product creation. The Canadian technical team is made up of technical experts from Canada, Colorado and California in the areas of extraction, product creation, and management of retail locations (where permitted). Anahit’s commitment is to use our Canadian expertise to benefit an emerging sector in developing economies in a manner that’s responsible, accessible and economical.
Key Management Bios
Darren Carrigan, COO
Darren has extensive experience working in a variety of advisory, M&A and valuation engagements for multiple Cannabis companies both private and public, within Canadian and international markets. He is a key driver of projects in the Caribbean region, overseeing and working with local governments as well as private sector partners to develop and refine current production practices. Darren has more than a decade of capital markets experience and is a Chartered Investment Manager (CIM).
Sameet Kanade, CEO
Most recently, Sameet co-founded Molecular Science Corp. He has over a decade of experience at investment banks in Toronto in equity research and structured finance in senior roles. Prior to entry into capital markets, he worked at PricewaterhouseCoopers and Ernst & Young. Sameet holds a Bachelor in Commerce and MBA (University of Toronto), and is an Associate Member of the Inst. of Chartered Accountants of India.
Frank Bellotti, Chairman
A seasoned financier and entrepreneur, Frank Bellotti has assisted in raising over a $1 billion of start-up and growth capital over the course of his 25-year career. The financier for The Hydropothecary Corporation (TSXV: THCX); Frank designed the financial structuring and was the original financier and investor for iAnthus Capital Holdings, Inc. (CSE: IAN | OTCQB: ITHUF). In 2016 he co-founded Molecular Science Corp., a life sciences company that provides product development, formulations and testing, terpene and cannabis genetics, commercial research and value-added services to the regulated cannabis sector.
Dr. Alexander Macgregor
Dr. Alexander MacGregor is the Dean of Faculty, distinguished professor of Biopharmaceutics and current president of the Toronto Institute of Pharmaceutical Technology (TIPT®) – North America’s premier post-graduate institute of pharmaceutical sciences, technology and research.
Dr. MacGregor is also a pharmaceutical science inventor, and expert in pharmaceutical technology and novel drug delivery systems. He is a recipient of several global patents in the field of medical treatments and pharmaceutical drug delivery technologies most notably from Canada, USA, Australia, Europe, Latin America, China, India and Japan.
Dr. MacGregor is a noted expert in translating pharmaceutical knowledge into sustainable business. He was a consultant to multi-national pharmaceutical companies such as GlaxoSmithKline, Valeant, Teva, Patheon, SunPharma, Beijing Double-Crane Pharma. He was appointment by the Government of China as an International Advisor in the field of pharmaceutical technology and research through a nomination by the City of Beijing and Beijing Double-Crane Pharmaceutical Co: China’s third largest pharmaceutical company.
Dr. MacGregor has authored and co-authored several articles and manuscripts in the field of pharmaceutical science and technology. He is the founding member and Chair of the Canadian Association of Pharmaceutical Technologists (CapTech), the founding member and past-Chair of the Toronto Pharmaceutical Ethics Committee, a member of several scientific associations like the prestigious Control Release Society (CRS), Canadian Society of Pharmaceutical Sciences (CSPS) and the American Association of Pharmaceutical Sciences (AAPS).
Dr. Steven Rothstein
Dr. Steven Rothstein received his PhD from the University of Wisconsin and did his postdoctoral training in Cambridge UK at the Plant Breeding Institute. He was a Senior Scientist for Ciba Geigy in their Agricultural Biotechnology Research Unit located at the Research Triangle Park, North Carolina. Following this, Dr. Rothstein was recruited to be the Pioneer Hi-Bred Industrial Research Chair in Plant Molecular Biology at the University of Guelph where later he also served as Chair of the Department of Molecular Biology and Genetics.
Later he returned to the private sector, working for Pioneer Hi-Bred as the Research Director for Agronomic Traits where he was in charge of a number of areas including the development of the techniques for utilizing genomic information to improve the efficiency of plant breeding selection and also developing corn lines with improved drought tolerance.
Dr. Rothstein returned to the University of Guelph in 2002 where he is the University Research Chair in Plant Molecular Genetics and Professor in the Department of Molecular and Cellular Biology.
Dr. Rothstein is a recognized international expert in the field of Plant Genetics and in particular developing an understanding of how crop plants respond to environmental stress like drought as well as the use of genomic information to study these problems. He has published over 130 peer reviewed research articles and been an inventor on over 15 patents.
Dr. Jose Casaretto
Dr. José Casaretto obtained his Ph.D. (Plant Biology) and postdoctoral training at Washington University in St. Louis, Missouri. He led a research group in the Institute of Plant Biology and Biotechnology at the University of Talca, Chile, and was director and co-investigator of over ten research projects focused on studying different aspects of plant metabolism and stress tolerance in crops. As part of those efforts, he established collaborative research with groups in Asia, Europe, and Latin America.
Dr. Casaretto currently works as a Research Scientist at the University of Guelph where he has used genomics tools to investigate regulatory networks of plant metabolic pathways. His experience is endorsed by a track record of high impact publications and as an evaluator for different funding agencies.